Lista de obras - Sergi Mas - Dominio Público Uruguay

-141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population

artículo científico publicado en 2008

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

artículo científico publicado en 2015

A common variant of the ABO gene protects against hypertension in a Spanish population

article

A functional variant provided further evidence for the association of ARVCF with schizophrenia

artículo científico publicado en 2010

A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

artículo científico publicado en 2021

ARVCF single marker and haplotypic association with schizophrenia.

artículo científico publicado en 2009

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

artículo científico publicado en 2015

Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example

artículo científico publicado en 2015

Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder

artículo científico publicado en 2015

Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder

artículo científico publicado en 2015

Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population

artículo científico publicado en 2008

Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders

artículo científico publicado en 2016

Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine

artículo científico publicado en 2017

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

scientific article published on 02 May 2019

CYP2D63, 4, 5 AND 6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY

Cancer, genes, and catechol estrogen metabolites

artículo científico publicado en 2003

Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study

artículo científico publicado en 2013

Correction: Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity

artículo científico publicado en 2017

DNA Cards: Determinants of DNA Yield and Quality in Collecting Genetic Samples for Pharmacogenetic Studies

artículo científico publicado en 2007

DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results

artículo científico publicado en 2021

Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation.

artículo científico publicado en 2004

Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics

artículo científico publicado en 2006

Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial

Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients

artículo científico publicado en 2014

Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components

artículo científico publicado en 2007

Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.

artículo científico publicado en 2016

Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

artículo científico publicado en 2016

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia

artículo científico publicado en 2016

Fluoxetine pharmacogenetics in child and adult populations.

artículo científico

Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies

artículo científico

Gene expression study in monocytes: evidence of inflammatory dysregulation in early-onset obsessive-compulsive disorder

artículo científico publicado en 2022

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

scientific article published on 07 May 2019

Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder

artículo científico publicado en 2017

Identification of <i>EP300</i> as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

artículo científico publicado en 2021

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

artículo científico publicado en 2018

Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients

artículo científico publicado en 2013

Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain.

artículo científico publicado en 2005

Induction of apoptosis in HT-29 cells by extracts from isothiocyanates-rich varieties of Brassica oleracea

artículo científico publicado en 2007

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population

artículo científico publicado en 2008

Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity

artículo científico publicado en 2016

Integrative DNA Methylation and Gene Expression Analysis of Cognitive Behavioral Therapy Response in Children and Adolescents with Obsessive-Compulsive Disorder; a Pilot Study

artículo científico publicado en 2021

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

artículo científico publicado en 2017

Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes

artículo científico publicado en 2009

Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes

artículo científico publicado en 2010

Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1

artículo científico publicado en 2007

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

artículo científico publicado en 2017

Modelling gene-environment interaction in first episodes of psychosis

artículo científico publicado en 2017

Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.

artículo científico publicado en 2015

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

artículo científico publicado en 2015

Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells

artículo científico publicado en 2011

One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms

artículo científico publicado en 2016

Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

artículo científico publicado en 2019

Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway

artículo científico publicado en 2014

Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes

artículo científico publicado en 2011

Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway.

artículo científico publicado en 2016

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

artículo científico publicado en 2016

Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.

artículo científico publicado en 2014

Polimorfismos genéticos en la catecol-O-metiltransferasa y riesgo de esquizofrenia en población española

artículo científico publicado en 2008

Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders

artículo científico publicado en 2008

Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers

Role of GAD2 and HTR1B genes in early-onset obsessive-compulsive disorder: results from transmission disequilibrium study

artículo científico publicado en 2014

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

artículo científico publicado en 2010

Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial

artículo científico publicado en 2013

SiNoPsis: Single Nucleotide Polymorphisms selection and promoter profiling

artículo científico publicado en 2017

Simultaneous genotyping of CYP2C92, 3, and 5' flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis

artículo científico publicado en 2005

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.

artículo científico publicado en 2012

Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress

artículo científico publicado en 2011

The effect of age on DNA concentration from whole saliva: Implications for the standard isolation method

scientific article published on 28 July 2014

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

artículo científico publicado en 2020

Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.

artículo científico publicado en 2010

Lista de obras de Sergi Mas

-141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

A common variant of the ABO gene protects against hypertension in a Spanish population

A functional variant provided further evidence for the association of ARVCF with schizophrenia

A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

ARVCF single marker and haplotypic association with schizophrenia.

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example

Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder

Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder

Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population

Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders

Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY

Cancer, genes, and catechol estrogen metabolites

Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study

Correction: Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity

DNA Cards: Determinants of DNA Yield and Quality in Collecting Genetic Samples for Pharmacogenetic Studies

DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results

Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation.

Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics

Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial

Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients

Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components

Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.

Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia

Fluoxetine pharmacogenetics in child and adult populations.

Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies

Gene expression study in monocytes: evidence of inflammatory dysregulation in early-onset obsessive-compulsive disorder

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

Human-leukocyte antigen class II genes in early-onset obsessive-compulsive disorder

Identification of <i>EP300</i> as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients

Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain.

Induction of apoptosis in HT-29 cells by extracts from isothiocyanates-rich varieties of Brassica oleracea

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population

Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity

Integrative DNA Methylation and Gene Expression Analysis of Cognitive Behavioral Therapy Response in Children and Adolescents with Obsessive-Compulsive Disorder; a Pilot Study

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes

Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes

Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

Modelling gene-environment interaction in first episodes of psychosis

Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells

One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms

Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway

Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes

Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway.

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder.

Polimorfismos genéticos en la catecol-O-metiltransferasa y riesgo de esquizofrenia en población española

Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders

Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers

Role of GAD2 and HTR1B genes in early-onset obsessive-compulsive disorder: results from transmission disequilibrium study

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial

SiNoPsis: Single Nucleotide Polymorphisms selection and promoter profiling

Simultaneous genotyping of CYP2C9*2, *3, and 5' flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.

Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress

The effect of age on DNA concentration from whole saliva: Implications for the standard isolation method

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.

CYP2D63, 4, 5 AND 6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY

Simultaneous genotyping of CYP2C92, 3, and 5' flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis